Robert P Edwards Selected Research

Estrogens (Estrogen)

12/2018	The Evolution of Estrogen Receptor Signaling in the Progression of Endometriosis to Endometriosis-Associated Ovarian Cancer.
1/2016	Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.
4/2014	Hormone receptor expression patterns in the endometrium of asymptomatic morbidly obese women before and after bariatric surgery.
7/2012	Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert P Edwards Research Topics

Disease

71	Neoplasms (Cancer) 10/2023 - 12/2002
59	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 07/2004
18	Endometrial Neoplasms (Endometrial Cancer) 07/2019 - 08/2006
16	Carcinoma (Carcinomatosis) 04/2022 - 01/2004
16	Ovarian Epithelial Carcinoma 01/2021 - 01/2010
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 01/2004
6	Endometriosis 12/2018 - 11/2009
5	Weight Loss (Weight Reduction) 09/2019 - 04/2014
5	Vaginal Neoplasms (Cancer, Vaginal) 01/2018 - 10/2006
5	Inflammation (Inflammations) 05/2015 - 01/2002
4	Vulvar Neoplasms (Vulvar Cancer) 01/2019 - 04/2006
4	Obesity 05/2017 - 12/2014
4	Ascites 11/2014 - 01/2011
3	Fallopian Tube Neoplasms 01/2020 - 07/2014
3	Adenocarcinoma 01/2019 - 04/2007
3	Morbid Obesity 05/2017 - 04/2014
3	Nausea 01/2016 - 07/2009
3	Infections 07/2009 - 01/2002
2	Fatigue 01/2022 - 11/2014
2	Disease Progression 01/2021 - 01/2015
2	Wound Infection (Wound Infections) 01/2017 - 04/2013
2	Vomiting 11/2014 - 07/2009
1	Bites and Stings (Sting) 07/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Constipation 01/2022
1	Premature Birth (Birth, Premature) 01/2021
1	COVID-19 01/2021
1	Margins of Excision 07/2019
1	Abdominal Obesity 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Death (Near-Death Experience) 09/2018

Drug/Important Bio-Agent (IBA)

13	PlatinumIBA 11/2022 - 02/2010
13	Biomarkers (Surrogate Marker)IBA 11/2022 - 07/2005
9	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 04/2007
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2010
6	Hormones (Hormone)IBA 01/2018 - 08/2012
6	Oral ContraceptivesIBA 01/2018 - 01/2002
5	Interleukin-2 (IL2)IBA 08/2013 - 07/2004
4	CytokinesIBA 01/2023 - 07/2013
4	Interleukin-12 (IL 12)IBA 01/2023 - 01/2002
4	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2004
4	Estrogens (Estrogen)FDA Link 12/2018 - 07/2012
4	AntibodiesIBA 09/2015 - 11/2009
4	belotecanIBA 02/2012 - 02/2009
4	VaccinesIBA 10/2009 - 05/2004
3	AntigensIBA 10/2023 - 11/2009
3	LigandsIBA 10/2023 - 12/2011
3	Immune Checkpoint InhibitorsIBA 07/2023 - 09/2015
3	RNA (Ribonucleic Acid)IBA 11/2022 - 12/2014
3	Complement System Proteins (Complement)IBA 11/2022 - 12/2014
3	ChemokinesIBA 01/2022 - 07/2012
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 07/2014
3	Docetaxel (Taxotere)FDA Link 01/2019 - 11/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 05/2014
3	ProstaglandinsIBA 04/2016 - 12/2011
3	InterleukinsIBA 08/2013 - 07/2004
3	CXCR4 Receptors (CXCR4 Receptor)IBA 07/2012 - 12/2011
3	Prostaglandins EIBA 01/2012 - 11/2011
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2004
2	Estrogen Receptor alphaIBA 12/2018 - 07/2017
2	Estrogen ReceptorsIBA 12/2018 - 07/2012
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2017 - 03/2012
2	MicroRNAs (MicroRNA)IBA 01/2016 - 03/2013
2	Mucin-1 (CA 15-3 Antigen)IBA 09/2015 - 11/2009
2	Glycoproteins (Glycoprotein)IBA 01/2014 - 11/2009
2	Fluorouracil (Carac)FDA LinkGeneric 04/2013 - 05/2008
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2012 - 11/2011
2	Papillomavirus Vaccines (HPV Vaccines)IBA 11/2009 - 02/2009
1	AutoantigensIBA 10/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2023
1	FollistatinIBA 01/2023
1	NFATC Transcription FactorsIBA 01/2023
1	taxaneIBA 04/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	ribociclibIBA 01/2022
1	Everolimus FDA Link 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Monomeric GTP-Binding ProteinsIBA 01/2018
1	poly(I).poly(c12,U) (ampligen)IBA 01/2018

Therapy/Procedure

32	Drug Therapy (Chemotherapy) 10/2023 - 01/2004
24	Therapeutics 10/2023 - 07/2004
19	Brachytherapy 07/2019 - 08/2006
17	Radiotherapy 07/2019 - 04/2006
8	Hysterectomy 07/2019 - 04/2008
6	Immunotherapy 01/2023 - 08/2007
6	Neoadjuvant Therapy 04/2022 - 06/2011
6	Bariatric Surgery 09/2019 - 04/2014
6	Hyperthermic Intraperitoneal Chemotherapy 12/2018 - 04/2007
4	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2014 - 04/2006
3	Cytoreduction Surgical Procedures 01/2019 - 03/2008
3	Tubal Sterilization (Tubal Ligation) 01/2016 - 03/2011
3	Lymph Node Excision (Lymph Node Dissection) 01/2015 - 04/2008
2	Aftercare (After-Treatment) 11/2015 - 12/2014
2	Debridement 04/2013 - 05/2008
2	Catheters 03/2010 - 07/2009
1	Ambulatory Care (Outpatient Care) 01/2021
1	Vulvectomy 01/2019
1	Maintenance Chemotherapy 12/2018